Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study (Q35605535)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2006
edit
Language Label Description Also known as
English
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study
scientific article published on January 2006

    Statements

    Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study (English)
    Serge D Steinfeld
    Nick K W Teoh
    William A Wegener
    David M Goldenberg
    Olivier Pradier
    1 January 2006

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit